Insider Trading April 15, 2026 09:39 AM

Insider Jorey Chernett Buys $52,000 of Airsculpt Technologies Stock

Ten-percent owner increases stake with 20,000-share purchase as company posts slight Q4 2025 beat amid volatile price action

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
AIRS

Jorey Chernett, a 10% owner of Airsculpt Technologies, purchased 20,000 shares on April 14, 2026, at a weighted average price of $2.60, a $52,000 transaction that raises his direct holdings to 7,013,761 shares. The move comes as AIRS shares trade at $2.75 after a six-month decline and a year-to-date gain, and follows the company's fourth-quarter 2025 results that modestly topped expectations.

Insider Jorey Chernett Buys $52,000 of Airsculpt Technologies Stock
AIRS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Jorey Chernett, a 10% owner of Airsculpt Technologies, purchased 20,000 shares on April 14, 2026, at a weighted average price of $2.60, for a total of $52,000.
  • Following the purchase, Chernett directly owns 7,013,761 shares of Airsculpt Technologies.
  • Airsculpt reported Q4 2025 EPS of -$0.02 versus an expected -$0.0286 and revenue of $34.56 million versus a $34.51 million forecast; the stock moved lower in pre-market trading despite the beats.

Jorey Chernett, who holds a ten percent ownership stake in Airsculpt Technologies, Inc. (NASDAQ:AIRS), bought 20,000 shares of the company's common stock on April 14, 2026, according to a Form 4 filing with the Securities and Exchange Commission.

The purchase was executed at a weighted average price of $2.60 per share, with individual trade prices reported in the filing between $2.59 and $2.61. The total cost of the transaction was $52,000. After this acquisition, Chernett's direct ownership in Airsculpt Technologies stands at 7,013,761 shares.


The insider purchase occurred while the stock was trading at $2.75. The share price has shown notable volatility, reflecting a six-month decline of 75% even as the stock has posted a year-to-date gain of 32%.

In addition to the filing, market commentary cited InvestingPro analysis indicating that Airsculpt Technologies appears to be trading near its Fair Value estimate. The InvestingPro coverage referenced in the filing notes that further InvestingPro Tips and Pro Research Reports are available for AIRS and a broader set of over 1,400 U.S. equities.


Airsculpt Technologies also released its fourth-quarter 2025 financial results. The company reported earnings per share of -$0.02, compared with analysts' projection of -$0.0286, representing a positive surprise of 30.07 percent. Quarterly revenue came in at $34.56 million, narrowly above the forecasted $34.51 million.

Despite the modest upside in both earnings and revenue versus expectations, the company's stock fell in pre-market trading. The filing and reporting noted that this decline may reflect broader market influences or investor concerns related to declining same-store sales, although no additional causal claims were presented in the disclosure.


These developments - an insider purchase by a significant shareholder alongside results that marginally exceeded analyst estimates - provide additional data points for investors evaluating Airsculpt Technologies amid pronounced recent price swings.

Risks

  • Significant recent share-price volatility - the stock has fallen 75% over six months - which may affect investor entry and exit decisions and reflects market risk.
  • Pre-market decline after Q4 2025 results suggests sensitivity to broader market influences and concerns over same-store sales, introducing demand and operational uncertainties.
  • Fair value assessments cited indicate valuation considerations; trading near fair value may limit immediate upside absent new catalysts.

More from Insider Trading

Luxfer Holdings Director Richard J. Hipple Offloads $60,350 in Shares Following RSU Conversion Jun 15, 2026 Luxfer Holdings Director Lisa Trimberger Offloads $60,350 Worth of Equity Jun 15, 2026 Luxfer Holdings Director Patrick Mullen Offloads Shares Amid Recent Equity Grants and Earnings Beat Jun 15, 2026 Luxfer Holdings Director Snowdon Sells $60,425 in LXFR Stock Jun 15, 2026 Tonix Pharmaceuticals Director Acquires Shares Amid Pipeline Expansion and Coverage Growth Jun 15, 2026